4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone has been researched along with Cardiac Failure in 2 studies
4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone: Inhibitor of phosphodiesterases.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mathew, R | 1 |
| Wang, J | 1 |
| Gewitz, MH | 1 |
| Hintze, TH | 1 |
| Wolin, MS | 1 |
| Matsumori, A | 1 |
| Ono, K | 1 |
| Sato, Y | 1 |
| Shioi, T | 1 |
| Nose, Y | 1 |
| Sasayama, S | 1 |
2 other studies available for 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone and Cardiac Failure
| Article | Year |
|---|---|
Congestive heart failure alters receptor-dependent cAMP-mediated relaxation of canine pulmonary arteries.
Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Animals; Colforsin; Cyclic AMP; Cyclic GMP; Dogs; He | 1993 |
Differential modulation of cytokine production by drugs: implications for therapy in heart failure.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzy | 1996 |